AstraZeneca and X-Chem are to expand their existing drug discovery collaboration, it has emerged. The partnership marks the third agreement between the pair since 2012, and builds on a relationship that has already seen the licensing of a number of novel small molecules across multiple discovery programmes and therapeutic indications.
Reageer